Lenalidomide, Bortezomib, and Dexamethasone with Transplantation for Myeloma
Lenalidomide, Bortezomib, and Dexamethasone with Transplantation for Myeloma is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Lenalidomide, Bortezomib, and Dexamethasone with Transplantation for Myeloma have?
Lenalidomide, Bortezomib, and Dexamethasone with Transplantation for Myeloma has 1,244 citations in the OpenAlex counts ScholarIQ stores.
When was Lenalidomide, Bortezomib, and Dexamethasone with Transplantation for Myeloma published?
Lenalidomide, Bortezomib, and Dexamethasone with Transplantation for Myeloma has 2017 year in the ScholarIQ index.
What is the open-access status of Lenalidomide, Bortezomib, and Dexamethasone with Transplantation for Myeloma?
Lenalidomide, Bortezomib, and Dexamethasone with Transplantation for Myeloma has bronze oa status in the ScholarIQ index.
What is the DOI of Lenalidomide, Bortezomib, and Dexamethasone with Transplantation for Myeloma?
The DOI for Lenalidomide, Bortezomib, and Dexamethasone with Transplantation for Myeloma is on the source record.
What is the PMID of Lenalidomide, Bortezomib, and Dexamethasone with Transplantation for Myeloma?
The PMID for Lenalidomide, Bortezomib, and Dexamethasone with Transplantation for Myeloma is on the source record.
What is the OpenAlex record for Lenalidomide, Bortezomib, and Dexamethasone with Transplantation for Myeloma?
The OpenAlex for Lenalidomide, Bortezomib, and Dexamethasone with Transplantation for Myeloma is on the source record.